The Phase II project of the Feiman Bio Changchun Jingyue Factory, undertaken by the Group Company, has officially commenced.


The Phase II project of the Feiman Bio Changchun Jingyue Factory, undertaken by the Group Company, has officially commenced construction.

On April 28, a grand groundbreaking ceremony was held for the Phase II project of the Feiman Bio Changchun Jingyue Factory, which is being constructed by the Group. Zhang Jian, General Manager of the company, Xu Bing, Deputy General Manager, and other senior executives attended the ceremony.

This project is being developed under an engineering, procurement, and construction (EPC) contracting model, with a planned gross floor area exceeding 20,000 square meters and a contract value of more than RMB 200 million. Construction is being undertaken by the Group’s Jinhui Branch. Leveraging Feiman Bio’s technological breakthroughs in the field of active collagen, the project will establish a full-industry-chain ecosystem spanning research and development to production, with the aim of setting a benchmark for the biopharmaceutical industry. At the groundbreaking ceremony, General Manager Zhang Jian delivered a speech, stating that Jiangsu Qian’an will fully leverage its expertise in pharmaceutical infrastructure construction, honor its commitments through pragmatic action, and reciprocate the trust placed in it with uncompromising quality. Mr. Zhang urged the project team to spare no effort in creating greater value for the client, ensuring the project’s high-quality execution, and ushering in a new chapter of mutually beneficial cooperation between the two parties. The successful commencement ceremony marks the entry of Jiangsu Qian’an’s collaboration with Feiman Biotechnology into a new phase, while also underscoring Jiangsu Qian’an’s professional expertise and technological strengths in the pharmaceutical infrastructure sector. Moving forward, the two parties will leverage this project as a strategic link to further deepen their cooperation, jointly driving innovation and development in the biopharmaceutical and medical aesthetics industries, and contributing to regional economic growth and industry advancement. (Jinhui Branch)

Recommended news


The Group dispatched representatives to attend the Exchange Meeting on Construction Project Quality and Safety Management and the On-site Observation Session.

In late September, the China Construction Enterprise Management Association organized an experience-sharing and on-site observation conference on quality and safety management in construction projects in Guangzhou, which was attended by representatives from the Group.


Empowering Communities Through Health: Experts Bring Science-Based Education to Qian’an

On September 18, Jiangsu Qian’an Construction Group, in collaboration with the Science Education Base of Qidong People’s Hospital, hosted the 2026 National Science Popularization Event.


Benchmarking against global standards! The Jotun Zhangjiagang project has successfully passed the safety audit conducted by its Norwegian headquarters.

In mid-September, a foreign‑owned expert audit team from Jotun’s Norwegian headquarters conducted a three‑day, headquarter‑level specialized safety audit on the Jotun Zhangjiagang project site undertaken by the Group.


The Roche (Shanghai) project of the Group has successfully achieved 2 million safe man-hours.

On September 17, the Roche (Shanghai) Biopharmaceutical Production Base project, undertaken by the Group, successfully reached the milestone of 2 million safe man-hours.


The Group dispatched personnel to attend the training on building trustworthy quality teams in chemical engineering construction.

On September 16–17, the China Chemical Construction Enterprises Association held a training course on building “Quality‑Trusted Work Teams” in Chengdu, with representatives from the Group in attendance. The session featured a live lecture by Shi Jie, a senior expert of the Association.


Good News Abounds | The Group Has Secured Multiple Emerging Industry Projects in Succession

In the golden autumn season, bountiful harvests abound, and new‑generation growth sectors showcase their strength. Since August, leveraging its deep-rooted expertise and core competencies in industrial installation, the Group has successively won bids for five key projects in emerging productivity fields, with a total contract value exceeding RMB 250 million, injecting robust momentum into its resilient year‑end performance.